Akt2 deficiency is associated with anxiety and depressive behavior in mice

Cellular Physiology and Biochemistry

Volumn 32, Issue 3, 2013, Pages 766-777

  Leibrock, Christina ^a   Ackermann, Teresa F ^a   Hierlmeier, Michael ^a   Lang, Florian ^a   Borgwardt, Stefan ^b   Lang, Undine E ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Akt2; Anxiety; BDNF; Behavior; Depression; GSK3; PI3K

Indexed keywords

PROTEIN KINASE B BETA; BRAIN DERIVED NEUROTROPHIC FACTOR; GLYCOGEN SYNTHASE KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIORAL RESEARCH; COGNITION; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FORCED SWIMMING TEST; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN DEFICIENCY; FEAR; FORCED SWIM TEST; GENOTYPE; KNOCKOUT MOUSE; MEMORY; MOOD; MORRIS WATER MAZE TEST; REARING; WILD TYPE;

MUS;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; DISEASE MODELS, ANIMAL; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84885006091     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354478     Document Type: Article

References (45)

1. Acebes A, Morales M: At a pi3k crossroads: Lessons from flies and rodents. Rev Neurosci 2012;23: 29-37.
2. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J: Molecular mechanisms of schizophrenia. Cell Physiol Biochem 2007;20: 687-702.
3. Mizuno M, Yamada K, Takei N, Tran MH, He J, Nakajima A, Nawa H, Nabeshima T: Phosphatidylinositol 3-kinase: A molecule mediating bdnf-dependent spatial memory formation. Mol Psychiatry 2003;8: 217-224.
4. Lang UE, Hellweg R, Gallinat J: Bdnf serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 2004;29: 795-798.
5. Lang UE, Hellweg R, Gallinat J: Association of bdnf serum concentrations with central serotonergic activity: Evidence from auditory signal processing. Neuropsychopharmacology 2005;30: 1148-1153.
6. Lang UE, Hellweg R, Kalus P, Bajbouj M, Lenzen KP, Sander T, Kunz D, Gallinat J: Association of a functional bdnf polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 2005;180: 95-99.
7. Duman RS, Monteggia LM: A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006;59: 1116-1127.
8. Deuschle M, Gilles M, Scharnholz B, Lederbogen F, Lang UE, Hellweg R: Changes of serum concentrations of brain-derived neurotrophic factor (bdnf) during treatment with venlafaxine and mirtazapine: Role of medication and response to treatment. Pharmacopsychiatry 2013;46: 54-58.
9. Ricken R, Adli M, Lange C, Krusche E, Stamm T, Koehler S, Nase S, Bschor T, Richter C, Steinacher B, Heinz A, Rapp M, Borgwardt S, Hellweg R, Lang U: Reduced bdnf serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants. J Clin Psychopharmacol 2013; in press.
10. Kobayashi T, Cohen P: Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (pdk1) and pdk2. Biochem J 1999;339: 319-328.
11. Shi HS, Zhu WL, Liu JF, Luo YX, Si JJ, Wang SJ, Xue YX, Ding ZB, Shi J, Lu L: Pi3k/akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3. Neuropsychopharmacology 2012;37: 2671-2683.
12. Budni J, Lobato KR, Binfare RW, Freitas AE, Costa AP, Martin-de-Saavedra MD, Leal RB, Lopez MG, Rodrigues AL: Involvement of pi3k, gsk-3beta and ppargamma in the antidepressant-like effect of folic acid in the forced swimming test in mice. J Psychopharmacol 2012;26: 714-723.
13. Aubry JM, Schwald M, Ballmann E, Karege F: Early effects of mood stabilizers on the akt/gsk-3beta signaling pathway and on cell survival and proliferation. Psychopharmacology (Berl) 2009;205: 419-429.
14. Gould TD, Manji HK: Glycogen synthase kinase-3: A putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 2005;30: 1223-1237.
15. Klein PS, Melton DA: A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996;93: 8455-8459.
16. Lu XH, Dwyer DS: Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in pc12 cells via pi3k/akt, erk, and pertussis toxin-sensitive pathways. J Mol Neurosci 2005;27: 43-64.
17. Zhang X, Mi J, Wetsel WC, Davidson C, Xiong X, Chen Q, Ellinwood EH, Lee TH: Pi3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity. Biochem Biophys Res Commun 2006;340: 1144-1150.
18. Pattwell SS, Bath KG, Casey BJ, Ninan I, Lee FS: Selective early-acquired fear memories undergo temporary suppression during adolescence. Proc Natl Acad Sci USA 2011;108: 1182-1187.
19. Ackermann TF, Kempe DS, Lang F, Lang UE: Hyperactivity and enhanced curiosity of mice expressing pkb/sgk-resistant glycogen synthase kinase-3 (gsk-3). Cell Physiol Biochem 2010;25: 775-786.
20. Ackermann TF, Hortnagl H, Wolfer DP, Colacicco G, Sohr R, Lang F, Hellweg R, Lang UE: Phosphatidylinositide dependent kinase deficiency increases anxiety and decreases gaba and serotonin abundance in the amygdala. Cell Physiol Biochem 2008;22: 735-744.
21. Diez H, Garrido JJ, Wandosell F: Specific roles of akt iso forms in apoptosis and axon growth regulation in neurons. PLoS One 2012;7:e32715.
22. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ: Akt1/pkbalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 2001;276: 38349-38352.
23. Yang ZZ, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, Perentes E, Hemmings BA: Protein kinase b alpha/akt1 regulates placental development and fetal growth. J Biol Chem 2003;278: 32124-32131.
24. Carter CJ: Eif2b and oligodendrocyte survival: Where nature and nurture meet in bipolar disorder and schizophrenia? Schizophr Bull 2007;33: 1343-1353.
25. Carter CJ: Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: Implications for oligodendrocyte viability. Neurochem Int 2007;50: 461-490.
26. Maier W, Zobel A, Kuhn KU: Clinical impact of recently detected susceptibility genes for schizophrenia. Dialogues Clin Neurosci 2006;8: 79-84.
27. Detera-Wadleigh SD: Lithium-related genetics of bipolar disorder. Ann Med 2001;33: 272-285.
28. Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS, Lee VM, Szabolcs M, de Jong R, Oltersdorf T, Ludwig T, Efstratiadis A, Birnbaum MJ: Role for akt3/protein kinase bgamma in attainment of normal brain size. Mol Cell Biol 2005;25: 1869-1878.
29. Tschopp O, Yang ZZ, Brodbeck D, Dummler BA, Hemmings-Mieszczak M, Watanabe T, Michaelis T, Frahm J, Hemmings BA: Essential role of protein kinase b gamma (pkb gamma/akt3) in postnatal brain development but not in glucose homeostasis. Development 2005;132: 2943-2954.
30. Poduri A, Evrony GD, Cai X, Elhosary PC, Beroukhim R, Lehtinen MK, Hills LB, Heinzen EL, Hill A, Hill RS, Barry BJ, Bourgeois BF, Riviello JJ, Barkovich AJ, Black PM, Ligon KL, Walsh CA: Somatic activation of akt3 causes hemispheric developmental brain malformations. Neuron 2012;74: 41-48.
31. Baek ST, Gibbs EM, Gleeson JG, Mathern GW: Hemimegalencephaly, a paradigm for somatic postzygotic neurodevelopmental disorders. Curr Opin Neurol 2013;26: 122-127.
32. Sarnat H, Flores-Sarnat L, Crino P, Hader W, Bello-Espinosa L: Hemimegalencephaly: Foetal tauopathy with mtor hyperactivation and neuronal lipidosis. Folia Neuropathol 2012;50: 330-345.
33. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB, III, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ: Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase akt2 (pkb beta). Science 2001;292: 1728-1731.
34. Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, McNeish JD, Coleman KG: Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking akt2/pkb beta. J Clin Invest 2003;112: 197-208.
35. Li G, Anderson RE, Tomita H, Adler R, Liu X, Zack DJ, Rajala RV: Nonredundant role of akt2 for neuroprotection of rod photoreceptor cells from light-induced cell death. J Neurosci 2007;27: 203-211.
36. Vojtek AB, Taylor J, DeRuiter SL, Yu JY, Figueroa C, Kwok RP, Turner DL: Akt regulates basic helix-loop-helix transcription factor-coactivator complex formation and activity during neuronal differentiation. Mol Cell Biol 2003;23: 4417-4427.
37. Speed NK, Matthies HJ, Kennedy JP, Vaughan RA, Javitch JA, Russo SJ, Lindsley CW, Niswender K, Galli A: Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression. ACS Chem Neurosci 2010;1: 476-481.
38. Dulawa SC, Grandy DK, Low MJ, Paulus MP, Geyer MA: Dopamine d4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci 1999;19: 9550-9556.
39. Mohajeri MH, Madani R, Saini K, Lipp HP, Nitsch RM, Wolfer DP: The impact of genetic background on neurodegeneration and behavior in seizured mice. Genes Brain Behav 2004;3: 228-239.
40. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase b. Nature 1995;378: 785-789.
41. Jope RS: Glycogen synthase kinase-3 in the etiology and treatment of mood disorders. Front Mol Neurosci 2011;4: 16.
42. Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I, Daneels G, Bouwknecht JA, Steckler T: Transgenic mice overexpressing glycogen synthase kinase 3beta: A putative model of hyperactivity and mania. J Neurosci 2006;26: 9022-9029.
43. Mines MA, Yuskaitis CJ, King MK, Beurel E, Jope RS: Gsk3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile x syndrome and autism. PLoS One 2010;5:e9706.
44. Beaulieu JM: A role for akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. J Psychiatry Neurosci 2012;37: 7-16.
45. Lang UE, Jockers-Scherubl MC, Hellweg R: State of the art of the neurotrophin hypothesis in psychiatric disorders: Implications and limitations. J Neural Transm 2004;111: 387-411.